Monitor whether Nantahala converts to a 13D (activist) filing, given the significant increase in stake and the company's micro-cap status with a $4M market cap. The 164,915 shares acquirable via convertible securities add potential future dilution.
CRIS drugs
CRIS drug pipeline →Price Chart
How similar events traded
Executive Summary
Nantahala Capital Management filed an amended Schedule 13G disclosing beneficial ownership of 258,739 shares (9.99% of outstanding common stock) of Curis Inc. as of September 30, 2026, up from 108,143 shares (4.328%) in its prior filing. The increase reflects additional share and warrant holdings, but the filing remains a passive 13G, indicating no activist intent.
Key Financial Metrics
Key Facts
- Nantahala Capital Management disclosed beneficial ownership of 258,739 shares of Curis Inc. common stock as of September 30, 2026.
- The stake represents 9.99% of outstanding shares, up from 4.328% in the prior filing.
- Of the 258,739 shares, 164,915 are acquirable within 60 days through convertible securities.
- The filing remains a passive Schedule 13G, with no activist intent indicated.
Financial Impact
Nantahala increased its stake from 108,143 shares to 258,739 shares, a 139% increase in share count.
Risk Factors
- Passive 13G status could change to activist 13D if Nantahala engages with management or seeks board representation.
- Convertible securities represent potential future dilution of 6.4% of current outstanding shares.
- Company has no revenue and a narrow cash runway into Q1 2027, increasing reliance on equity financing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001104659-26-127181 |
| Document: 0001104659-26-127181-index.html | 0001104659-26-127181 |
| Document: 0001104659-26-127181.txt | 0001104659-26-127181 |
Track record
18 reports on CRIS
7 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +82.45% at T+60 after the May 22, 2026 report. 9 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $0.4200 Now $0.4400 +4.76% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $0.6000 Now $0.4400 −26.67% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.5010 Now $0.4400 −12.18% settles Nov 17
- Nov 13, 20263d ago S-3 Bearish 7/10 Entry $0.6000 Now $0.4400 +26.67% settles Nov 17
- Nov 13, 20263d ago 8-K Neutral 4/10 Entry $0.4450 Now $0.4400 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $0.4450 to $0.4358 Now $0.4400 +1.12% ▲ +2.07% +0.16% vs SPY
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $0.6530 to $0.5915 Now $0.4400 −32.62% ▼ −9.42% −10.74% vs SPY
- Nov 6, 202610d ago 8-K Bearish 7/10 Entry $0.6976 to $0.6530 Now $0.4400 +36.93% ▲ +6.39% +6.03% vs SPY
- Nov 2, 202614d ago DEF 14A Neutral 4/10 Entry $0.6610 to $0.7139 Now $0.4400 −33.43% ▲ +8.00% +7.70% vs SPY
- Oct 19, 202628d ago 8-K Bearish 6/10 Entry $0.3996 to $0.3920 Now $0.4400 −10.11% ▲ +1.90% +2.43% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers